PEN Stock Chart & Fundamental Analysis

Fundamentals Charts

About PENUMBRA INC

Name

PENUMBRA INC

CEO

Adam Elsesser

Website

www.penumbrainc.com

Industry

Healthcare

Year Founded

2004

Employees

4,700

Penumbra, Inc. develops and sells medical technology for vascular and neuro interventions, trading on the NYSE as PEN. In healthcare, it focuses on devices used to remove clots, treat aneurysms and other lesions, and support neurosurgical evacuation, with $1.4 billion in FY2025 revenue.

Analyst Ratings

Consensus Recommendation

Buy3

Hold3

Sell1

Fundamentals & Financials

Revenue (TTM)

$1.4B

Net Income (TTM)

$171M

EPS (TTM)

$4.38

ROA (TTM)

9.01%

Current Ratio

6.02

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q1 FY2026	Q4 FY2025	Q3 FY2025
Revenue	$374,758K	$385,385K	$354,685K
Cost of Sales	$121,347K	$123,257K	$114,269K
Gross Profit	$253,411K	$262,128K	$240,416K
Operating Income	$38,234K	$59,233K	$48,838K
Net Income	$32,584K	$47,343K	$45,851K
EPS	$0.83	$1.21	$1.17

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

PENUMBRA INC's Technical Indicators Summary

PEN’s technicals favor a buy stance as the stock trades at and slightly above its short- and medium-term moving averages and remains above the 200-day average, indicating longer-term support. Momentum is muted but the CCI is positive and MACD is neutral to constructive, while RSI and money flow show balanced demand. Volatility is low, reflecting calm price action, and on-balance volume is positive, supporting the recent price stability. The classic pivot sits near the current quote, marking a nearby decision point. Technical takeaway: maintain a buy bias.

Buy

3 signals

Neutral

3 signals

Sell

1 signal

Overall: Bullish43% Bullish signals

Indicator	Value	Signal	Explanation
ADX (14)	9.45	Neutral	Weak or consolidating trend (ADX < 25). ADX(9.45), +DI(20.94), -DI(16.19)
RSI (14)	49.54	Neutral	RSI (49.54) is neutral.
Stochastic %K (14, 3, 3)	65.33	Neutral	Stochastic (65.33) is neutral.
CCI (20)	118.32	Buy	CCI (118.32) > 100, indicating strong upward momentum.
WPR (14)	-32.70	Neutral	Williams %R (-32.70) is neutral.
Momentum (10)	-0.25	Sell	Momentum (-0.25) is negative.
MFI	52.09	Neutral	MFI (52.09) is neutral.
MACD Level (12, 26)	-0.50	Neutral	Potential bullish reversal: MACD (-0.50) crossed above signal but is still negative.
Bollinger Bands	$315.11 - $319.62	Neutral	Price is within the bands.
ATR (14)	$2.20 (0.69%)	Neutral	Low Volatility (0.69%) suggests stability.
OBV	16,049,013	Buy	Bullish volume pressure: OBV is above its 20-day SMA. OBV(16,049,013), 20D-SMA-OBV(15,604,125)
Classic Pivot Point	$318.99	Sell	Price ($318.32) has broken below support S1 ($318.38) — bearish momentum confirmed.
Fibonacci Pivot Point	$318.99	Neutral	Price ($318.32) below pivot ($318.99) but above support S1 ($318.29) — mildly bearish, not confirmed.
Exponential Moving Averages	$305.10 - $320.71(5 indicators)	Buy	EMA group: 3/5 bullish, 2 bearish, 0 neutral. Price above key EMA averages.
Simple Moving Averages	$312.44 - $326.72(5 indicators)	Buy	SMA group: 3/5 bullish, 2 bearish, 0 neutral. Price above key SMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

PEN ended the session -0.16% below yesterday's close of 318.01. Into the bell, a soft sector rise of 0.63% left a constructive backdrop for PEN. PEN's growth focus after the latest quarter could sustain its momentum.

Trading Volume

Below 10d avg (360.7K)

188.1K

vs S&P 500 Today

Underperforming Market

-1.06%

52-Week Position

Upper range

68.2%

Updated: July 21, 2026 at 20:09 UTC